Exchanges through the blood-brain barrier;Les échanges à travers la barrière hémato-encéphalique

Annales Pharmaceutiques Francaises

Volumn 60, Issue 6, 2002, Pages 372-379

  Scherrmann, J M ^a,b  

^a Faculté de Pharmacie ^*  (France)

^b HÔPITAL FERNAND WIDAL   (France)

Author keywords

Endothelial cells; Metabolism; P glycoprotein; Permeability; Transport

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; AMITRIPTYLINE; ANTHRACYCLINE; ANTIMITOTIC AGENT; CARBAMAZEPINE; CHLORPROMAZINE; CYTOCHALASIN B; CYTOCHROME P450; ENZYME; ETOPOSIDE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE; GLYCOPROTEIN P; INSULIN; LEPTIN; MELPHALAN; PROTEINASE INHIBITOR; PSYCHOTROPIC AGENT; SAQUINAVIR; SULFOTRANSFERASE; VINCA ALKALOID; ZIDOVUDINE;

BLOOD BRAIN BARRIER; BRAIN CAPILLARY; CAPILLARY ENDOTHELIUM; CONFERENCE PAPER; DRUG TRANSPORT; ENDOTHELIUM CELL; FENESTRATION; NUTRIENT; PERMEABILITY; TIGHT JUNCTION; TRANSCYTOSIS;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD-AQUEOUS BARRIER; ENDOTHELIUM, VASCULAR; HUMANS;

EID: 0036863204     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Pardridge WM. Transport of small molecules through the blood-brain barrier: Biology and methodology. Adv Drug Del Rev. 1995; 17: 713-31.
2. st Ed. Boca Raton: CRC Press; 1996:49-91.
3. Pardridge WM. Drug delivery to the brain. J Cereb Blood Flow Metab. 1997; 17: 713-31.
4. Lefauconnier JM et Hauw JJ. La barrière hématoencéphalique. I Données morphologiques. Revue Neurologie (Paris) 1983; 139, 11: 611-24.
5. Goldstein GW, Betz AL. The blood-brain barrier. Sci American 1986; 255: 74-83.
6. Frank RN, Dutas-Mancini MA. Pericyte coverage is greater in the retinal than in the cerebral capillaries of the rat. Invest Ophtalmol Visual Sci. 1987; 28: 1089-91.
7. Balabanov R, Dore-Duffy P. Role of the CNS microvascular pericyte in the blood-brain barrier. J Neurosci Res. 1998; 53: 637-44.
8. Bertossi M, Virgintino D, Maiorano E, Occhiogrosso M, Roncali L. Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct Pathol. 1997; 21: 41-9.
9. Stewart PA, Wiley MJ. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: A study using quail-chick transplantation chimeras. Dev Biol. 1981; 84: 183-92.
10. Krum JM, Kenyon KL, Rosenstein JM. Expression of blood-brain barrier characteristics following neuronal loss and astroglial damage after administration of antithy-1 immunotoxin. Exp Neurol. 1997; 146: 33-45.
11. Brightman MW. Morphology of blood-brain interfaces. Exp Eye Res. 1977; 25: 1-25.
12. Drewes LR. Molecular architecture of the brain microvasculature. J Mol Neurosc. 2001; 16: 93-8.
13. Temsamani J, Scherrmann JM, Rees AR, Kaczorek M. Brain drug delivery technologies: Novel approaches for transporting therapeutics. Pharmc Sci Technol Today. 2000; 2: 49-59.
14. Oldendorf WH, Cornform ME, Brown WJ. The large apparent work capability of the blood-brain barrier: A study of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol. 1977; 1: 409-17.
15. Betz AL, Firth JA, Goldstein GW. Polarity of the blood- brain barrier: Distribution of enzymes between the luminal and antiluminal membranes of brain capillary endothelial cells. Brain Res. 1980; 192: 17-28.
16. Minn A, Ghersi-Egea JF, Perrin R, Leininger B, Siest G. Drug metabolizing enzymes in the brain and cerebral microvessels. Brain Res Rew. 1991; 16: 65-82.
17. Ghersi-Egea JF, Leninger-Muller B, Suleman G, Siest G, Minn A. Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circum-ventricular organs. J Neurochem. 1994; 62: 1089-96.
18. Britto MR, Wedlung PJ. Cytochrome P-450 in the brain. Potential evolutionary and therapeutic relevance of localization of drug-metabolizing enzymes. Drug Met Disp. 1992; 20: 446-50.
19. Montoliu C, Vallés S, Renau-Piqueras J, Guerri C. Ethanol-induced oxygen radical formation and lipid peroxidation in rat brain: Effects of chronic alcohol comsumption. J Neurochem. 1994; 63: 1855-62.
20. Chen ZR, Irvine RJ, Bochner F, Somogyi AA. Morphine formation in rat brain: A possible mechanism of codeine analgesia. Life Sci. 1990; 46: 1067-74.
21. Gould GW, Holman GD. The glucose transporter family: Structure, function and tissue specific expression. Biochem J. 1993; 295: 329-41.
22. +-independent neutral amino acid transporter with broad substrate slectivity. J Biol Chem. 1999; 274: 19745-51.
23. +) of the rat blood-brain barrier. J Neurochem. 1993; 60: 1956-9.
24. Gerhart DZ, Emerson BE, Zhdankina OY, Leino RL, Drewes LR. Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats. Am J Physiol. 1997; 273: E 207-13.
25. Tamai T, Tsuji A. Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci. 2000; 89: 1371-88.
26. Drion N, Lemaire M, Lefauconnier JM, Scherrmann JM. Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine. J Neurochem. 1996; 67: 1688-93.
27. Huai-Yun H, Secrest DT, Mark KS, Carney D, Elmquist WF, Miller W. Expression of multi-drug resistance-associated protein (MRP) in brain microvessel endothelial cells. Biochem Biophys Res Commun. 1998; 243: 816-20.
28. Fricker G, Miller D, Bauer B, Nobmann S, Gutmann H, Török M et al. Transport of xenobiotics across isolated brain microvessels studied by confocal microscopy. Presented at the 3rd FEBS Advanced Lecture Course-ABC2001 Gosau, Austria.
29. Rousselle C, Smirnova M, Clair P, Lefauconnier JM, Chavanieu A, Calas B et al. Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: Saturation kinetics and specificity. J Pharmacol Exp Ther. 2001; 296: 124-31.
30. Temsamani J, Scherrmann JM, Rees AR, Kaczorek M. Brain drug delivery technologies: Novel approaches for transporting therapeutics. Pharmc Sci Technol Today. 2000; 2: 49-59.
31. Jolliet-Riant P, Tillement JP. Drug transfer across the blood-brain barrier and improvement of brain delivery. Fundam. Clin. Pharmacol. 1999; 13: 16-26.